Goodwin Procter LLP advised Kymab on the deal, while Weil advised Sanofi. Kymab announced its agreement under which Sanofi will acquire Kymab for an upfront payment of…
Sanofi’s $1.1 Billion Acquisition Of Kymab


Goodwin Procter LLP advised Kymab on the deal, while Weil advised Sanofi. Kymab announced its agreement under which Sanofi will acquire Kymab for an upfront payment of…
…